Otlk stock forecast 2025 currency fluctuations may indirectly

Currency fluctuations may indirectly shape otlk stock forecast 2025 given OTLK’s potential international partnerships. A weaker USD could boost overseas revenue streams, improving full-year valuation outlooks. To be sure, undersized biotech names represent one of the most volatile entities. Further, OTLK – as one of the speculative stocks under $1 – takes this unpredictable profile to the extreme. In the trailing one-year period, OTLK suffered a loss of 65%. Since its public market debut in 2016, Outlook lost almost 99%. This document is distributed in the Dubai International Financial Centre by Morgan Stanley Investment Management Limited (Representative Office), an entity regulated by the Dubai Financial Services Authority (“DFSA”). It is intended for use by professional clients and market counterparties only. This document is not intended for distribution to retail clients, and retail clients should not act upon the information contained in this document. The otlk stock forecast 2025 shows mixed sentiment among analysts, with revenue growth expectations driven by upcoming clinical trial milestones in the biotech sector. Current estimates suggest OTLK could trade between $2.80 and $4.50 if positive Phase 3 data emerges, reflecting sector volatility and investor appetite for biotech plays.